01 8AbbVie Corporation
Patent Expiration Date : 2032-10-19
Date Granted : 2015-04-21
Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir Sodium
Brand Name : HOLKIRA PAK
Patent Number : 2851104
Filing Date : 2012-10-19
Strength per Unit : 12.5 mg / 75 mg / 50 mg / 250 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-10-19
Date Granted : 2015-04-21
Patent Expiration Date : 2030-06-10
Date Granted : 2014-10-21
Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir Sodium
Brand Name : HOLKIRA PAK
Patent Number : 2737601
Filing Date : 2010-06-10
Strength per Unit : 12.5 mg / 75 mg / 50 mg / 250 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-06-10
Date Granted : 2014-10-21
Patent Expiration Date : 2028-09-17
Date Granted : 2014-06-17
Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir Sodium
Brand Name : HOLKIRA PAK
Patent Number : 2699986
Filing Date : 2008-09-17
Strength per Unit : 12.5 mg / 75 mg / 50 mg / 250 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-09-17
Date Granted : 2014-06-17
Patent Expiration Date : 2019-07-19
Date Granted : 2009-11-17
Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir Sodium
Brand Name : HOLKIRA PAK
Patent Number : 2510949
Filing Date : 1999-07-19
Strength per Unit : 12.5 mg / 75 mg / 50 mg / 250 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2019-07-19
Date Granted : 2009-11-17
Patent Expiration Date : 2019-07-19
Date Granted : 2006-02-21
Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir Sodium
Brand Name : HOLKIRA PAK
Patent Number : 2337846
Filing Date : 1999-07-19
Strength per Unit : 12.5 mg / 75 mg / 50 mg / 250 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2019-07-19
Date Granted : 2006-02-21
Patent Expiration Date : 2016-06-28
Date Granted : 2002-08-27
Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir Sodium
Brand Name : HOLKIRA PAK
Patent Number : 2224738
Filing Date : 1996-06-28
Strength per Unit : 12.5 mg / 75 mg / 50 mg / 250 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2016-06-28
Date Granted : 2002-08-27
Patent Expiration Date : 2032-10-19
Date Granted : 2015-08-11
Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir Sodium
Brand Name : HOLKIRA PAK
Patent Number : 2811250
Filing Date : 2012-10-19
Strength per Unit : 12.5 mg / 75 mg / 50 mg / 250 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-10-19
Date Granted : 2015-08-11
Patent Expiration Date : 2029-09-10
Date Granted : 2016-02-09
Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir Sodium
Brand Name : HOLKIRA PAK
Patent Number : 2736895
Filing Date : 2009-09-10
Strength per Unit : 12.5 mg / 75 mg / 50 mg / 250 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-09-10
Date Granted : 2016-02-09
